| Name | Title | Contact Details |
|---|
Introducing QXO.
Greater Iowa Credit Union (GICU) is a member-owned financial cooperative established in June 1932 by a group of Iowa State University employees. It has grown to serve over 36,000 members across a 33-county area in Central and Western Iowa, managing assets between $624 million and $667 million. GICU is federally insured and state-chartered, emphasizing its commitment to the financial well-being of its members and the communities it serves. GICU offers a range of financial services typical of credit unions, including banking services like checking and savings accounts, loans for personal, auto, and business needs, and possibly investment services. The credit union operates nine branch locations in cities such as Ames, Ankeny, and Des Moines, providing localized service. GICU is also dedicated to community engagement, having received recognition as the Best Credit Union in Crawford County and Story County multiple times.
The Big Biscuit, founded in 2000, is an All-American breakfast and lunch concept focusing on freshly prepared classic comfort food consistently served with generous portions in a family-friendly environment. The Big Biscuit has 27+ locations in Kansas, Missouri, Oklahoma, and Arkansas
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Strategic Gears is the biggest local management consultancy firm in Saudi Arabia; It has offices in Egypt, Qatar and UK. Providing multidisciplinary services for both the private and public sectors. The company offers consulting solutions in the areas of Strategy, Marketing, Organizational Excellence and Digital, to a range of clients in both the public and private sectors. The company is heavily involved in the transformation era of Saudi Arabia, driven by the Vision 2030 initiatives. Strategic Gears prides itself on its ability to be a knowledge hub for the Saudi market, publishing reports on a monthly basis on the current state of the Kingdoms economy as well as hot topics in both the public and private sectors, including an annual coverage of the Saudi budget, and other reports on the Kingdoms macroeconomic performance, labour market, digital transformation and AI, among others. The company, which was founded in late 2015, has quickly evolved from a small team to more than 230 employees in all its branches.